Veracyte
The firm also shared validation data at ASCO 2021 on its nasal swab classifier to help guide treatment decisions for patients with indeterminate lung nodules.
Veracyte Bladder Cancer Test Receives Medicare Coverage
The patient must be a candidate for multiple potential treatments with varying levels of intensity or multiple therapies.
GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April
The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.
Veracyte to Acquire HalioDx for €260M
Veracyte said the acquisition will help accelerate its in vitro diagnostic test development and manufacturing operations in Europe.
Veracyte Q1 Revenues Up 18 Percent; CEO Transition Underway
The firm posted first quarter revenues of $36.7 million, up from $31.1 million a year ago and above analysts' average estimate of $32.7 million.
Feb 17, 2021
Veracyte Q4 2020 Revenues Rise 16 Percent
Aug 5, 2020
Veracyte Prices $180M Public Stock Offering
Jul 30, 2020